(19)

(11)

EP 4 125 711 A1

(12)

(43) Date of publication: 08.02.2023 Bulletin 2023/06 (21) Application number: 21775343.3 (22) Date of filing: 17.03.2021

(51) International Patent Classification (IPC):  A61F 2/00(1985.01) (52) Cooperative Patent Classification (CPC): A61F 2/0063; A61F 2002/0081; A61F 2210/0004; A61F 2210/0076; A61F 2240/001; A61F 2250/0067; A61F 2250/0031; A61F 2250/0068 (86) International application number: PCT/US2021/022691 (87) International publication number: WO 2021/194817 (30.09.2021 Gazette 2021/39)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 26.03.2020 US 202016831169 11.01.2021 US 202117146305 (71) Applicant: Markman Biologics Corporation Las Vegas, NV 89135 (US)	(72) Inventor: MARKMAN, Barry Las Vegas, NV 89135 (US) (74) Representative: Potter Clarkson  The Belgrave Centre Talbot Street Nottingham NG1 5GG Nottingham NG1 5GG (GB)